US HB1344 | 2019-2020 | 116th Congress

Status

Spectrum: Partisan Bill (Democrat 22-0)
Status: Introduced on February 25 2019 - 25% progression
Action: 2019-03-25 - Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Pending: House Subcommittee on Antitrust, Commercial, and Administrative Law Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Competitive DRUGS Act of 2019 Competitive Deals Resulting in Unleashed Generics and Savings Act of 2019

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Competitive DRUGS Act of 2019 Competitive Deals Resulting in Unleashed Generics and Savings Act of 2019

Sponsors


History

DateChamberAction
2019-03-25HouseReferred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
2019-02-25HouseReferred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-25HouseReferred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-25HouseReferred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-02-25HouseIntroduced in House

Same As/Similar To

HB2375 (Related) 2019-04-30 - Ordered to be Reported by Voice Vote.

Subjects


US Congress State Sources


Bill Comments

feedback